Virchow Laboratories is an API manufacturer based in India. It holds one active US drug master file and one valid CEP. Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 6 June 2024 as VAI. Customs aggregates show $22.0M of exports covering 435 molecules to 49 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Ida Jeedimetla Hyderabad, India | 3003649250 |
| Hyderabad, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Sulfamethoxazole | EDQM, US FDA | 2 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $4.5M | 29 |
| 2025 | Not reported | $22.0M | 49 |
| 2024 | Not reported | $20.4M | 54 |
| 2023 | Not reported | $34.1M | 53 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Virchow Laboratories comes back tiered against every other supplier able to file there.
Start for free